March 12, 2019 / 1:22 PM / 2 months ago

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 (Reuters) - British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

Smith and Nephew will pay Osiris shareholders $19 in cash for each share they hold. Osiris shares closed at $18.88 on the Nasdaq on Monday. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below